Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION

v3.23.3
SHARE-BASED COMPENSATION
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
SHARE-BASED COMPENSATION

 

15. SHARE-BASED COMPENSATION

 

2021 Stock Incentive Plan

 

Prior to the Business Combination, the Company maintained its 2009 Omnibus Equity Compensation Plan (the “2009 Plan” and together with the 2021 Plan, the “Plans”). Upon Closing of the Business Combination, awards under the 2009 Plan were converted at the exchange ratio calculated in accordance with the Business Combination Agreement and the 2021 Plan became effective. On June 21, 2022, the 2021 Plan was amended and restated to, among other things, increase the number of shares of Common Stock authorized for issuance under the 2021 Plan by 5,643,450 shares. As of September 30, 2023, there were 6,007,718 shares of Common Stock authorized for issuance under the amended and restated 2021 Plan, plus any shares of Common Stock subject to awards under the 2009 Plan that are forfeited or reacquired by the Company due to termination or cancellation. As of September 30, 2023, there were 13,932,936 shares of Common Stock authorized for issuance under the Plans.

 

The following table summarizes share-based compensation expense for the three and nine months ended September 30, 2023 and 2022 (in thousands):

 

                               
    Three Months Ended
September 30,
   

Nine Months Ended

September 30,

 
    2023     2022     2023     2022  
Research and development   $ 354     $ 1,007     $ 1,455     $ 3,142  
Sales and marketing     777       945       1,801       3,225  
General and administrative     970       3,835       2,768       12,850  
Cost of sales     6       76       20       182  
Total share-based compensation   $ 2,107     $ 5,863     $ 6,044     $ 19,399  

 

Common Stock Options

 

The following table sets forth the activity for all Common Stock options:

 

                               
    Number of
Shares
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life (Years)
    Weighted-
Average
Grant Date
Fair Value
 
Outstanding, December 31, 2022     7,812,178     $ 3.70       6.56     $ 2.23  
Granted     15,000       0.14       -       -  
Forfeited     (352,739 )     2.64       -       1.52  
Expired     (139,404 )     2.81       -       1.55  
Outstanding, September 30, 2023(a)     7,335,035     $ 3.76       4.86     $ 2.00  
Exercisable, September 30, 2023(b)     5,681,575     $ 3.91       4.03     $ 2.07  

 

 
(a) There was no aggregate intrinsic value of all stock options outstanding as of September 30, 2023.
(b) There was no aggregate intrinsic value of all vested/exercisable stock options as of September 30, 2023.

 

As of September 30, 2023, there was $2.3 million of unrecognized compensation expense related to stock options to be recognized over a weighted average period of 2.27 years.

 

Restricted Stock Units

 

As part of the consideration in the Business Combination, RSUs with respect to 1,750,000 shares of Common Stock were granted to the participants in Legacy Airspan’s MIP. For the RSUs granted to MIP Participants, the weighted average grant date fair value was $9.75 per RSU. The RSUs granted in connection with the MIP vested one year after the date of the grant. There were 681,620 restricted stock units granted to the directors during the nine months ended September 30, 2023. There were no restricted stock units granted to the employees during the nine months ended September 30, 2023.

 

The following table sets forth the activity for all RSUs:

 

               
    Number of
RSUs
    Weighted
Average
Grant Date
Fair Value
 
Outstanding (nonvested), December 31, 2022     4,267,746     $ 3.58  
Granted     681,620       0.56  
Released     (443,105 )     5.27  
Forfeited     (446,392 )     3.32  
Outstanding (nonvested), September 30, 2023     4,059,869     $ 2.92  

 

Because the Company maintained a full valuation allowance on its U.S. deferred tax assets, it did not recognize any tax benefit related to share-based compensation expense for the three and nine months ended September 30, 2023 and 2022. As of September 30, 2023, there was $6.5 million of unrecognized compensation expense related to RSUs to be recognized over a weighted average period of 1.48 years.